Literature DB >> 19215009

Inflammation in lone atrial fibrillation.

Shu-Yuan Yao1, Jian-Min Chu, Ke-Ping Chen, Min Tang, Pi-Hua Fang, Fang-Zheng Wang, Shu Zhang.   

Abstract

OBJECTIVES: This study was designed to evaluate the correlation between lone atrial fibrillation and inflammation.
METHODS: A total of 411 subjects were enrolled in this study, including 333 patients with lone atrial fibrillation, and 78 controls. C-reactive protein (CRP) and echocardiography were evaluated, and the electrocardiograph was monitored to identify cardiac rhythm at the time of blood sampling. According to the rhythm, paroxysmal atrial fibrillation was divided into presence and absence of atrial fibrillation.
RESULTS: Subjects with lone atrial fibrillation had higher CRP levels than controls (media, 1.00 mg/L; IQR, 1.00-2.54 versus media, 1.00 mg/L; IQR, 1.00-1.55; p = 0.016) and subjects with persistent atrial fibrillation had higher CRP levels than those with paroxysmal atrial fibrillation (media, 1.62 mg/L; IQR, 1.00-3.98 versus media, 1.00 mg/L, IQR, 1.00-2.10; p = 0.022), and so did presence of atrial fibrillation rather than absence of atrial fibrillation (media, 2.11 mg/L; IQR, 1.00-3.60 versus media, 1.00 mg/L; IQR, 1.00-1.76; p = 0.000) in paroxysmal atrial fibrillation. However, there was no significant difference in CRP levels between persistent atrial fibrillation and presence of atrial fibrillation in paroxysmal atrial fibrillation (p = 0.992). Neither was there any difference between absence of atrial fibrillation in paroxysmal atrial fibrillation and controls (p = 0.483). In patients with lone atrial fibrillation, atrial fibrillation rhythm (B = 4.85, 95%CI: 2.61-8.99) was the only independent predictor of elevated CRP levels after adjusted covariants.
CONCLUSIONS: Patients with lone atrial fibrillation had elevated CRP levels only when they were in atrial fibrillation rhythm and an elevated CRP level was not related to duration of time or history of atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215009      PMCID: PMC6653014          DOI: 10.1002/clc.20290

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  16 in total

1.  High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.

Authors:  Eiichi Watanabe; Tomoharu Arakawa; Tatsushi Uchiyama; Itsuo Kodama; Hitoshi Hishida
Journal:  Int J Cardiol       Date:  2005-06-17       Impact factor: 4.164

2.  Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation.

Authors:  C A Carnes; M K Chung; T Nakayama; H Nakayama; R S Baliga; S Piao; A Kanderian; S Pavia; R L Hamlin; P M McCarthy; J A Bauer; D R Van Wagoner
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

3.  Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation.

Authors:  Yosuke Ishii; Richard B Schuessler; Sydney L Gaynor; Kiyomi Yamada; Annabel S Fu; John P Boineau; Ralph J Damiano
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

4.  C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.

Authors:  M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

5.  High sensitivity C-reactive protein as an independent risk factor for essential hypertension.

Authors:  Ki Chul Sung; Jung Yul Suh; Bum Soo Kim; Jin Ho Kang; Hyang Kim; Man Ho Lee; Jung Ro Park; Sun Woo Kim
Journal:  Am J Hypertens       Date:  2003-06       Impact factor: 2.689

Review 6.  Angiotensin, inflammation, hypertension, and cardiovascular disease.

Authors:  F C Luft
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

7.  Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.

Authors:  Mayumi Saito; Toshihiko Ishimitsu; Junichi Minami; Hidehiko Ono; Masami Ohrui; Hiroaki Matsuoka
Journal:  Atherosclerosis       Date:  2003-03       Impact factor: 5.162

8.  Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.

Authors:  Dwayne S G Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

9.  The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.

Authors:  Koichiro Kumagai; Hideko Nakashima; Keijiro Saku
Journal:  Cardiovasc Res       Date:  2004-04-01       Impact factor: 10.787

10.  Inflammation as a risk factor for atrial fibrillation.

Authors:  Ronnier J Aviles; David O Martin; Carolyn Apperson-Hansen; Penny L Houghtaling; Pentti Rautaharju; Richard A Kronmal; Russell P Tracy; David R Van Wagoner; Bruce M Psaty; Michael S Lauer; Mina K Chung
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

View more
  11 in total

1.  Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset.

Authors:  Pier Luigi Pellegrino; Natale Daniele Brunetti; Luisa De Gennaro; Luigi Ziccardi; Massimo Grimaldi; Matteo Di Biase
Journal:  Intern Emerg Med       Date:  2011-03-30       Impact factor: 3.397

2.  Intracardiac and extracardiac markers of inflammation during atrial fibrillation.

Authors:  Gregory M Marcus; Lisa M Smith; Karen Ordovas; Melvin M Scheinman; Albert M Kim; Nitish Badhwar; Randall J Lee; Zian H Tseng; Byron K Lee; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2009-10-12       Impact factor: 6.343

Review 3.  Atrial Fibrillation and Risk of Dementia/Cognitive Decline.

Authors:  Anand D Shah; Faisal M Merchant; David B Delurgio
Journal:  J Atr Fibrillation       Date:  2016-02-29

Review 4.  Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Authors:  Roberto Galea; Maria Teresa Cardillo; Annalisa Caroli; Maria Giulia Marini; Chiara Sonnino; Maria L Narducci; Luigi M Biasucci
Journal:  Tex Heart Inst J       Date:  2014-10-01

5.  Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Authors:  Christian Pfluecke; Daniel Tarnowski; Lina Plichta; Katharina Berndt; Paul Schumacher; Stefan Ulbrich; Mathias Forkmann; Marian Christoph; David M Poitz; Carsten Wunderlich; Ruth H Strasser; Karim Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-09-28       Impact factor: 5.460

6.  Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.

Authors:  Tayfun Sahin; Eser Acar; Umut Celikyurt; Teoman Kılıc; Guliz Kozdag; Aysen Agacdiken; Dilek Ural
Journal:  Med Sci Monit       Date:  2012-02

7.  Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion: a meta-analysis.

Authors:  Peng Yan; Pingshuan Dong; Zhijuan Li; Jianxin Cheng
Journal:  Med Sci Monit       Date:  2014-12-21

8.  Evaluation of Atrial Conduction Times, Epicardial Fat Thickness and Carotid Intima-Media Thickness in Patients With Ankylosing Spondylitis.

Authors:  Sabri Onur Çağlar; İsmail Boyraz; Fatma Erdem; Selma Yazici; Hilal Çağlar; Bünyamin Koç; Emrah Çağlar; Mehmet Yazici
Journal:  Arch Rheumatol       Date:  2016-06-03       Impact factor: 1.472

9.  Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis.

Authors:  Xue Zhou; Jian-lin Du; Jia Yuan; Yun-qing Chen
Journal:  Int J Med Sci       Date:  2013-01-10       Impact factor: 3.738

10.  Serum Soluble Semaphorin 4D is Associated with Left Atrial Diameter in Patients with Atrial Fibrillation.

Authors:  Li Xiang; Tao You; Jianchang Chen; Weiting Xu; Yang Jiao
Journal:  Med Sci Monit       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.